Modern Advances in CARs Therapy and Creating a New Approach to Future Treatment

Genetically engineered T and NK cells expressing a chimeric antigen receptor (CAR) are promising cytotoxic cells for the treatment of hematological malignancies and solid tumors. Despite the successful therapies using CAR-T cells, they have some disadvantages, such as cytokine release syndrome (CRS)...

Descripción completa

Detalles Bibliográficos
Autores principales: Sadowski, Karol, Olejarz, Wioletta, Basak, Grzegorz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9739283/
https://www.ncbi.nlm.nih.gov/pubmed/36499331
http://dx.doi.org/10.3390/ijms232315006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9739283/
https://www.ncbi.nlm.nih.gov/pubmed/36499331
http://dx.doi.org/10.3390/ijms232315006

Ejemplares similares